Domini Social Investments Lowers stake in OraSure Technologies (OSUR)

OraSure Technologies (OSUR) : Domini Social Investments reduced its stake in OraSure Technologies by 20.47% during the most recent quarter end. The investment management company now holds a total of 60,495 shares of OraSure Technologies which is valued at $421,650 after selling 15,566 shares in OraSure Technologies , the firm said in a disclosure report filed with the SEC on Aug 12, 2016.OraSure Technologies makes up approximately 17.22% of Domini Social Investments’s portfolio.

Other Hedge Funds, Including , Group One Trading boosted its stake in OSUR in the latest quarter, The investment management firm added 2,765 additional shares and now holds a total of 4,019 shares of OraSure Technologies which is valued at $28,012.Dynamic Technology Lab Private Ltd boosted its stake in OSUR in the latest quarter, The investment management firm added 26,424 additional shares and now holds a total of 37,177 shares of OraSure Technologies which is valued at $259,124. OraSure Technologies makes up approx 0.07% of Dynamic Technology Lab Private Ltd’s portfolio.Blackrock Investment Management boosted its stake in OSUR in the latest quarter, The investment management firm added 942 additional shares and now holds a total of 215,332 shares of OraSure Technologies which is valued at $1,500,864.State Board Of Administration Of Florida Retirement System boosted its stake in OSUR in the latest quarter, The investment management firm added 3,358 additional shares and now holds a total of 55,387 shares of OraSure Technologies which is valued at $404,879. New York State Teachers Retirement System added OSUR to its portfolio by purchasing 4,900 company shares during the most recent quarter which is valued at $31,654.

OraSure Technologies opened for trading at $8.24 and hit $9 on the upside on Monday, eventually ending the session at $8.66, with a gain of 10.32% or 0.81 points. The heightened volatility saw the trading volume jump to 41,60,547 shares. Company has a market cap of $482 M.

On the company’s financial health, OraSure Technologies reported $0.07 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Aug 3, 2016. Analyst had a consensus of $0.05. The company had revenue of $31.36 million for the quarter, compared to analysts expectations of $31.18 million. The company’s revenue was up 3.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.03 EPS.

Many Wall Street Analysts have commented on OraSure Technologies. OraSure Technologies was Downgraded by Raymond James to ” Mkt Perform” on Jun 13, 2016.

OraSure Technologies Inc. (OraSure) is involved in the development manufacture marketing and sale of oral fluid diagnostic products and specimen collection devices and other diagnostic products designed to detect or diagnose critical medical conditions. These products include OraQuick In-Home HIV Test OraQuick ADVANCE OraSure HIV-1 oral specimen collection device OraQuick HCV rapid antibody test Intercept oral fluid drug testing system OraSure QuickFlu Rapid Flu A&B Test and Q.E.D. Saliva Alcohol test. The Company also manufactures and sells a range of cryosurgical products. Through its wholly owned subsidiary DNA Genotek Inc. the Company provides oral fluid sample collection stabilization and preparation products for molecular diagnostic applications.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *